Fluazinam Fungicide Faces EU Withdrawal Push After Brain Development Study July 12

A fungicide widely used across Europe to control fungal diseases in crops may harm brain development in exposed offspring, according to a re-analysis of a suppressed 2003-2004 study. Stockholm University researchers found that ISK Biosciences Europe, the manufacturer, never submitted the Huntingdon Life Sciences study to EU regulators during fluazinam’s 2009 renewal, despite evidence of significant adverse effects on rat brain development. Switzerland uses up to 10 metric tons of fluazinam annually, and the chemical has been detected in Swiss children.

How the study was hidden from regulators

A developmental neurotoxicity study conducted in 2003-2004 by Huntingdon Life Sciences found major adverse effects on brain development in offspring exposed to fluazinam before birth. The manufacturer never submitted this study during the pesticide’s 2009 EU renewal process, allowing fluazinam to remain approved. When researchers re-examined the original data, they identified multiple instances of false reporting and incorrect statistics that masked harmful effects.

What the new analysis revealed

Stockholm University scientists re-ran the 2005 study using the same statistical methods and found six instances where fluazinam exposure led to statistically significant impacts on brain development. They discovered decreases in brain weight and width in rat offspring. The researchers concluded that the original 2005 report’s conclusions were “entirely unreasonable and not supported by the results that should have been reported.” In 2024, 340 tonnes of fluazinam was sold in Germany alone.

Regulatory failures and Swiss exposure

EU authorities requested the study from the industry and reviewed it, but failed to apply appropriate analyses and accepted a threshold allowing brain effects in up to 10% of the population to be considered acceptable. This breaches core requirements of EU pesticide law aimed at ensuring high protection for human health. In Switzerland, fluazinam is used to control fungal diseases in potato, onion, fruit, and grapevine cultivation, with up to 10 metric tons of the active ingredient used annually. A Swiss study has detected fluazinam in children.

Systemic problems in pesticide approval

This is not the first regulatory fraud involving pesticides. A similar case was published in 2018, yet regulators have not taken measures against responsible industry parties or strengthened the system. A former Swiss federal toxicologist told the Tages-Anzeiger that authorities rely heavily on manufacturer-provided data and are often unable to verify it completely. The Federal Office for Food Safety and Veterinary Affairs rejected these allegations, stating that complete dossiers containing toxicological and ecotoxicological studies must be submitted and reviewed for approval.

Final Thoughts

The fluazinam case exposes systemic weaknesses in EU pesticide regulation that allowed a potentially neurotoxic chemical to remain approved for 17 years despite hidden evidence of harm. Swiss regulators and the EU face pressure to withdraw the fungicide and strengthen oversight of industry-sponsored studies.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.